Deutsche Telekom Faces Twin Test: Verizon's Surge and a Clinical AI Bet
Published on 10/28/2026 at 04:21 | Editorial boerse-global.de
Deutsche Telekom investors are being asked to weigh two very different propositions at once. One is immediate and competitive: Verizon reported 406,000 net new mobile contract customers yesterday, up sharply from 44,000 a year earlier, a figure that puts the resilience of T-Mobile US — the group's US majority stake — squarely under the microscope. The other is long-term and optional: a freshly announced Series B investment, made through T.Capital, in Swedish clinical AI specialist Tandem Health.
The Verizon numbers landed first, and they carry the louder message. They sharpen the question of whether T-Mobile US can hold its ground against established rivals and potential new entrants. But the data alone do not settle whether Verizon's gain came at T-Mobile's expense or whether both carriers are simply adding subscribers in a growing market. That distinction will matter far more than the headline figure when Deutsche Telekom reports third-quarter 2026 results on 5 November 2026.
A Warning Signal, Not Yet Proof
Verizon's success is a caution flag for Bonn, not evidence of customer losses at its US arm. The decisive metric is T-Mobile US's own contract customer development, which will show whether competitive anxiety is already biting into the business. Until those numbers arrive, the bear case rests largely on apprehension rather than confirmed damage.
A second worry has been circulating since Reuters reported on 9 October that SpaceX had struck an agreement to acquire a nationwide US low-band spectrum portfolio. Because of its majority holding in T-Mobile US, Deutsche Telekom sits directly in the path of that debate. Yet the two issues sit on different footing: Verizon has delivered hard subscriber figures, while SpaceX represents a hypothetical future entrant whose competitive impact remains unproven. For operational assessment, reported business results carry more weight than assumptions about a market participant that does not yet compete.
Should investors sell immediately? Or is it worth buying Deutsche Telekom?
The Analyst Divide
Opinion on the sell side is split. Deutsche Bank's Robert Grindle reaffirmed his buy rating and EUR 40 price target on 19 October, and according to media reports he considered the market reaction to the planned SpaceX entry overdone. Barclays took a different tack on 20 October, cutting its target to EUR 32 from EUR 35 while keeping a positive rating; the bank flagged satellite technology and agentic AI as longer-term sector risks.
Those structural concerns stretch beyond any single reporting period. Solid quarterly figures might calm near-term nerves without proving that new technologies will leave T-Mobile US unscathed over time. Equally, it would be premature to read a spectrum deal as certain harm — the genuine risk is added competitive pressure, not demonstrated displacement.
Meanwhile, a Bet on Clinical Workflows
Deutsche Telekom's venture arm has taken a stake in Tandem Health's Series B round, a move announced today that targets AI applications in healthcare. Tandem builds an AI assistant for medical documentation, billing code assignment and clinical decision support. Its software is used in more than 10,000 healthcare facilities across 14 European countries, is integrated into roughly 130 patient record systems and holds Class IIa medical device certification under the EU Medical Device Regulation.
That footprint offers a base for growth but does not answer the investor question about future economic significance for Deutsche Telekom. The real test is whether Tandem can convert existing usage into a sustainably scalable business — and whether additional applications deepen customer relationships enough to generate value. The company is developing tools for patient navigation, appointment management and administration. CEO Lukas Saari has set an ambitious goal: returning one billion working hours to Europe's healthcare professionals. That is a target, not a realized saving. T-Systems, for its part, stresses that deployed AI must be trustworthy and secure, meaning Tandem would also have to meet its users' reliability demands.
Growth Without Earnings Is Not Enough
Even a thriving Tandem need not translate quickly into a tangible benefit for Telekom shareholders. Rollout of further applications could fall short of expectations, leaving the stake a future option rather than a valuation anchor. Group-level figures illustrate why expansion alone does not suffice: in the second quarter of 2026, revenue rose to EUR 29.93 billion from EUR 28.67 billion a year earlier, yet earnings per share slipped to EUR 0.51 from EUR 0.54. That comparison concerns the group as a whole and says nothing about Tandem's profitability, but it sets the bar against which any new growth story must be measured.
Deutsche Telekom at a turning point? This analysis reveals what investors need to know now.
Outside the US debate, the group can point to progress: yesterday it reported another win in the connect fixed-network test, earning the top mark of "outstanding" for the first time. That does not substitute for proof on T-Mobile US, but it does suggest the company should not be judged solely on possible shifts in the American mobile market.
What November Must Show
Attention now turns to T-Mobile US's quarterly figures, expected tomorrow, with the Stuttgarter Zeitung reporting that eyes are on the fallout from tougher US competition. The Telekom report follows on 5 November 2026. If the US stake keeps posting robust customer growth, Verizon's surge can be read as one carrier's success rather than a weakening of Deutsche Telekom's position, and the SpaceX debate may lose some of its sting. Should momentum fade, the competitive concerns gain substance and any recovery would depend on convincing counterarguments from management. Either way, the Tandem stake should be judged as a possible supplement to future growth — not a replacement for convincing results.
Ad
Deutsche Telekom Stock: New Analysis - 28 October
Fresh Deutsche Telekom information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
